ARCA Biopharma Inc ABIO:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:15 AM EDT
3.50quote price arrow up+0.18 (+5.42%)
Volume
1,384
Close
3.32quote price arrow down-0.08 (-2.35%)
Volume
65,104
52 week range
1.56 - 3.88
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.32
  • 52 Week High3.88
  • 52 Week High Date04/03/24
  • 52 Week Low1.56
  • 52 Week Low Date01/19/24

Key Stats

  • Market Cap48.164M
  • Shares Out14.51M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta0.95
  • YTD % Change95.29

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.32
  • 52 Week High3.88
  • 52 Week High Date04/03/24
  • 52 Week Low1.56
  • 52 Week Low Date01/19/24
  • Market Cap48.164M
  • Shares Out14.51M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta0.95
  • YTD % Change95.29

RATIOS/PROFITABILITY

  • EPS (TTM)-0.42
  • P/E (TTM)-7.99
  • Fwd P/E (NTM)-0.37
  • EBITDA (TTM)-7.968M
  • ROE (TTM)-15.87%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ARCA Biopharma Inc

 

Profile

MORE
ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company engaged in developing genetically and other targeted therapies for cardiovascular diseases through a precision medicine approach to drug development. The Company's lead product candidate is Gencaro (bucindolol hydrochloride) for the treatment of atrial fibrillation (AF) in patients with chronic heart failure (HF). Gencaro is being developed for patients who have a genotype that identifies a drug target...
Robert Conway CPA
Independent Chairman of the Board
Thomas Keuer
President, Principal Executive Officer, Chief Operating Officer
C. Jeffrey Dekker CPA
Chief Financial Officer
Address
10170 Church Ranch Way, Suite 100
Westminster, CO
80021
United States

Top Peers

SYMBOLLASTCHG%CHG
RVPH
Reviva Pharmaceuticals Holdings, Inc.
1.82+0.13+7.35%
CLNN
Clene Inc.
0.3841-0.0067-1.7144%
NXTC
NextCure Inc
1.59-0.01-0.62%
INTS
Intensity Therapeutics Inc
4.42+0.42+10.50%
AVRO
AVROBIO Inc
1.29-0.06-4.44%